NDC 51662-1455

AMIDATE(TM) ETOMIDATE

Amidate(tm) Etomidate

AMIDATE(TM) ETOMIDATE is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Etomidate.

Product ID51662-1455_99847797-99ec-40d4-e053-2995a90a972a
NDC51662-1455
Product TypeHuman Prescription Drug
Proprietary NameAMIDATE(TM) ETOMIDATE
Generic NameAmidate(tm) Etomidate
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2019-12-12
Marketing CategoryNDA / NDA
Application NumberNDA018227
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NameETOMIDATE
Active Ingredient Strength2 mg/mL
Pharm ClassesGeneral Anesthesia [PE],General Anesthetic [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 51662-1455-1

20 mL in 1 VIAL, SINGLE-DOSE (51662-1455-1)
Marketing Start Date2019-12-12
NDC Exclude FlagN
Sample Package?N

Drug Details

Active Ingredients

IngredientStrength
ETOMIDATE2 mg/mL

Pharmacological Class

  • General Anesthesia [PE]
  • General Anesthetic [EPC]

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.